Health or Wealth: The High Cost of Living Under Big Pharma’s Rule
As healthcare and pharmaceutical costs skyrocket, a troubling pattern of control and coercion emerges. With drug prices reaching unprecedented heights, millions face a dire choice: surrender financial stability for life-saving medication or seek affordable treatments abroad, often navigating legal grey areas. This article explores how multinational corporations, with the complicity of a largely acquiescent legislative and executive branch, orchestrate economic and social enslavement by manipulating drug prices and market access through patent monopolies and restrictive trade agreements. The influence of Big Pharma, extensive lobbying efforts, and government collusion maintain high prices and limit competition, affecting global healthcare access and patient well-being.